Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation ; volume:13 ; number:1 ; day:7 ; month:8 ; year:2018 ; pages:1-5 ; date:12.2018
Radiation oncology ; 13, Heft 1 (7.8.2018), 1-5, 12.2018
- Creator
-
Chen, Hanbo
- Contributor
-
Tikkanen, Jussi
Boldt, R. Gabriel
Louie, Alexander V.
SpringerLink (Online service)
- DOI
-
10.1186/s13014-018-1089-8
- URN
-
urn:nbn:de:101:1-2018100722385179536715
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Hanbo
- Tikkanen, Jussi
- Boldt, R. Gabriel
- Louie, Alexander V.
- SpringerLink (Online service)
Other Objects (12)
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer
Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer
Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer